The strategic goal of Flowonix Medical Incorporated (Flowonix) is to become the leading implantable drug delivery company in the world. Founded in 2005, Flowonix (then called Medasys) received approval to conduct its first clinical trial in 2007 on the Prometra programmable implantable pump.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/24/12 | $25,000,000 |
Clarus Ventures OmniCapital Fund RFT Investment Company | undisclosed | |
| 11/12/14 | $40,000,000 |
Clarus Ventures Elevage Capital Management Hercules Technology Growth Capital | undisclosed |
